This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Ispaghula as a lipid-lowering drug

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • can be used as an adjunct to lipid-lowering diet in patients with mild to moderate hypercholesterolaemia
  • probable mechanism of action via reduction of bile acid reabsorption; plasma triglyceride remains unchanged
  • caution advised in patients with diabetes mellitus; also need to maintain adequate fluid intake
  • contra-indications include intestinal obstruction, faecal impaction, colonic atony

The summary of product characteristics should be consulted before prescribing this drug.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.